🇺🇸 Triamcinolone acetonide injection in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Headache — 2 reports (18.18%)
  2. Blindness Transient — 1 report (9.09%)
  3. Blood Pressure Increased — 1 report (9.09%)
  4. Culture Wound Positive — 1 report (9.09%)
  5. Cushing^S Syndrome — 1 report (9.09%)
  6. Deep Vein Thrombosis — 1 report (9.09%)
  7. Drug Interaction — 1 report (9.09%)
  8. Dyspnoea — 1 report (9.09%)
  9. Feeling Hot — 1 report (9.09%)
  10. Herpes Zoster — 1 report (9.09%)

Source database →

Other Immunology, Rheumatology, Dermatology approved in United States

Frequently asked questions

Is Triamcinolone acetonide injection approved in United States?

Triamcinolone acetonide injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Triamcinolone acetonide injection in United States?

Somdech Phra Nangchao Sirikit Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.